20th November 2007 Cheshire, UK… The Clinical Trial Company (TCTC), one of the UK’s leading and fastest growing contract research organisation (CRO), is delighted to announce that it has opened a new office on the Cambourne Business Park near Cambridge, UK.
TCTC has seen a steady growth in demand for its clinical trials services from biotechnology and pharmaceutical companies in the Cambridge area. The office is expected to grow rapidly as the company recruits staff to support the business.
Rob Brown, Director of Business Development commented “The opening of this office demonstrates our commitment to clients in the area and also helps us to better serve companies throughout the whole of the South of England”
Ewan Campbell, one of TCTC’s co-founders remarked “The location of the new office fits in with our global growth strategy and allows us to provide talented clinical trial teams to clients while also giving easier access to Investigator sites in The Midlands and Southern England, reducing travelling time and minimising pass-through costs”
TCTC will continue with its world wide expansion which includes opening offices in Hong Kong and Australia in the near future.
The CLINICAL TRIAL Company is a privately-owned contract research organisation (CRO) headquartered in Knutsford, Cheshire, UK and with a North American office near Toronto Airport, Ontario, Canada.
TCTC provides full-service clinical studies and stand-alone clinical trial, regulatory and quality services to biotechnology, pharmaceutical and medical device companies throughout the world.
TCTC was established in 2000 and is one of the fastest growing CROs in Europe.
